戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  58 (38%) of whom had at least one puerperal psychotic episode.
2 tivity at 90% specificity in patients with a psychotic episode.
3 n antipsychotic drug for people with a first psychotic episode.
4 se risk in individuals remitted from a first psychotic episode.
5 cfDNA in the plasma of patients with a first psychotic episode.
6 disorders who were hospitalized for an acute psychotic episode.
7 hrenia-diagnosed human subjects with a first psychotic episode.
8 ance among patients experiencing their first psychotic episode.
9 ly treated patients experiencing their first psychotic episode and 16 healthy comparison subjects.
10 rn of deficits after treatment for the first psychotic episode and about relationships between these
11 n schizophrenic patients with a recent first psychotic episode and affective disorders among their re
12 onsequences, such as the occurrence of acute psychotic episodes and the development of chronic schizo
13 M-III-R criteria, who had had a recent first psychotic episode, and psychiatric diagnostic informatio
14 syndrome characterized by cerebellar ataxia, psychotic episodes, and obsessive behavior, as well as c
15 he hypothesis that the majority of puerperal psychotic episodes are manifestations of an affective di
16 ment on the risk of hospitalization due to a psychotic episode, as a marker for severe relapse, among
17 ge, sex, cannabis use, and duration of first psychotic episode, as well as for differences in clinica
18         The risk of hospitalization due to a psychotic episode associated with periods of antipsychot
19 ophrenic probands were examined at the index psychotic episode (at study entry) and systematically ov
20  and unstable moods, suffered from recurrent psychotic episodes during the last 2 years of his extrao
21  schizophrenia sample experiencing a current psychotic episode, explaining 27% of the variance in sym
22  D2 antagonists after remission from a first psychotic episode, extra monitoring during tapering is r
23 was defined as the occurrence of any mood or psychotic episode fulfilling DSM-IV-TR criteria.
24 ing criteria: 1) the length of their current psychotic episode had to be 5 or fewer years, and 2) pat
25 olar mood disorders (similar risk) and brief psychotic episodes (higher risk).
26 milial aggregation of postpartum (puerperal) psychotic episodes in women with bipolar disorder.
27 first 18 months after remission from a first psychotic episode, in 227 individuals who tapered antips
28                                    The first psychotic episode is often preceded by a long prodromal
29 t effectively prevents relapse after a first psychotic episode, many remitted antipsychotic users wis
30 proportions in many countries and can induce psychotic episodes mimicking the clinical profile of sch
31 with bipolar disorder experiencing a current psychotic episode (n = 16, r = 0.60, P = .01), which rem
32 in the plasma of patients during their first psychotic episode (n=29), compared with healthy controls
33          The highest risk of suicide after a psychotic episode occurs soon after presentation, yet ph
34 not solely either a reaction to having had a psychotic episode or part of the recovery process.
35 cidal behavior or ideation, extreme anxiety, psychotic episodes, or other extreme behavior likely to
36 ies, but only 44 (29%) experienced recurrent psychotic episodes over the 3-year study period, and onl
37 cially in patients who remitted from a first psychotic episode, remains unclear.
38  and poor response to treatment of the first psychotic episode were significant predicters of time to
39 en and three women) experiencing their first psychotic episode who had no previous history of antipsy
40 s at least one family member with a manic or psychotic episode with an onset within 6 weeks of delive